4 days left to exhibit at TechCrunch Disrupt 2026
In less than a month, 10,000+ founders, investors, operators, and tech leaders will walk into TechCrunch Disrupt 2026…
Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
Now, roughly 16 months later, the startup is in talks to raise new funding…
Meet the next wave of VCs judging Startup Battlefield 200 at TechCrunch Disrupt 2026
For founders, Startup Battlefield 200 is one of the biggest moments of their careers.…
Imperagen raises £5 million to use quantum physics, AI on enzyme engineering
Biotech company Imperagen announced on Thursday a £5 million ($6.7 million) seed round led…
The Builders Stage brings practical strategies for scaling startups to TechCrunch Disrupt 2026
The Builders Stage is returning to TechCrunch Disrupt 2026, bringing together founders, startup operators, and investors…
Insurers claim AI is already increasing healthcare costs
Hospitals' use of artificial intelligence tools as they submit insurance claims led to an…
I went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptides
I am sitting in the sweltering Nevada heat watching a man struggle to lift…
Health benefits platform Thatch reaches $1B valuation as healthcare costs surge
That's a remarkable valuation leap for a company that isn't, at its core, an…
Dimension Capital’s $800M third fund shows the intersection of science and compute is booming
While many newer VC firms are still struggling to raise fresh capital, Dimension Capital,…
Discover what’s next: 5 days left to save up to $200 on your TechCrunch Disrupt 2026 ticket
With five days left to save up to $200 on your TechCrunch Disrupt 2026…
The Path, founded by Tony Robbins and Calm alums, hopes to offer safer AI therapy
When the founders of a mental health app for men called Mental saw that…
Qualcomm backs Ultrahuman in $70M round on bet to turn smart rings into computers
In the meantime, Ultrahuman is also looking to work more closely with Labcorp, as…
Next five VCs judging Startup Battlefield 200 contenders at TechCrunch Disrupt 2026
Thousands of applications. Multiple rounds of review. Hundreds of hours spent evaluating startups from…
What happens in Vega$: steroids, swimmers, and a billion-dollar hustle
I am sitting in the sweltering Nevada heat watching a man struggle to lift…
Next wave of VCs judging Startup Battlefield 200 contenders at TechCrunch Disrupt 2026 revealed
A great pitch doesn't win Startup Battlefield 200. A great company does. That's why…
Science Corporation’s vision-restoring chip wins EU approval
Hodak says bringing PRIMA to market is "the most important thing for the company,…
